Back to search

Peptide record

TPDB25352

Antibacterial Toxicity standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB25352
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
standard
No
A 17-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
RVCFRVCRNGVCYRRCW
Physicochemical Analysis
C92H146N34O20S4
ADEQHILKMPST
R
2176.63
9.95
5
0
6
+5
-0.19
-0.188
51.18
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
7240
332.62
6
Residue Composition
number
0
A
5
R
1
N
0
D
4
C
0
E
0
Q
1
G
0
H
0
I
0
L
0
K
0
M
1
F
0
P
0
S
0
T
1
W
1
Y
3
V
Amino Acid Distribution
A: 0 R: 5 N: 1 D: 0 C: 4 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 0 K: 0 M: 0 F: 1 P: 0 S: 0 T: 0 W: 1 Y: 1 V: 3
Chemical Descriptors
17
C92H146N34O20S4
2176.63
9.95
+5
-0.19
-0.188
Evidence Records 9 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4 µM

Target

M. luteus B-1314

Source & Reference

NA

Other

active against Gram+ M. luteus B-1314 (MIC 4 uM), S. aureus 209P (MIC 4 uM), B. subtilis B-886 (MIC 16 uM), E. coli ML-35p or ATTC 25922 o
Evidence 2 Activity

Activity

MIC
Antibacterial
4 µM

Target

Staphylococcus aureus 209P

Source & Reference

NA

Other

active against Gram+ M. luteus B-1314 (MIC 4 uM), S. aureus 209P (MIC 4 uM), B. subtilis B-886 (MIC 16 uM), E. coli ML-35p or ATTC 25922 or CI 3600 or CI 214 (MIC 0.
Evidence 3 Activity

Activity

MIC
Antibacterial
16 µM

Target

B. subtilis B-886

Source & Reference

NA

Other

active against Gram+ M. luteus B-1314 (MIC 4 uM), S. aureus 209P (MIC 4 uM), B. subtilis B-886 (MIC 16 uM), E. coli ML-35p or ATTC 25922 or CI 3600 or CI 214 (MIC 0.25 uM), E. cloacae CI 4172 (MIC
Evidence 4 Activity

Activity

MIC
Antibacterial
0.25 µM

Target

Escherichia coli ML-35p or ATTC 25922 or CI 3600 or CI 214

Source & Reference

NA

Other

m+ M. luteus B-1314 (MIC 4 uM), S. aureus 209P (MIC 4 uM), B. subtilis B-886 (MIC 16 uM), E. coli ML-35p or ATTC 25922 or CI 3600 or CI 214 (MIC 0.25 uM), E. cloacae CI 4172 (MIC 2 uM), A. baumanii CI 2675 (MIC 0.25 uM), P. aeruginosa PAO1 (MI
Evidence 5 Activity

Activity

MIC
Antibacterial
2 µM

Target

Enterobacter cloacae CI 4172

Source & Reference

NA

Other

tilis B-886 (MIC 16 uM), E. coli ML-35p or ATTC 25922 or CI 3600 or CI 214 (MIC 0.25 uM), E. cloacae CI 4172 (MIC 2 uM), A. baumanii CI 2675 (MIC 0.25 uM), P. aeruginosa PAO1 (MIC 2 uM), and K. pneumonia ATCC
Evidence 6 Activity

Activity

MIC
Antibacterial
0.25 µM

Target

A. baumanii CI 2675

Source & Reference

NA

Other

i ML-35p or ATTC 25922 or CI 3600 or CI 214 (MIC 0.25 uM), E. cloacae CI 4172 (MIC 2 uM), A. baumanii CI 2675 (MIC 0.25 uM), P. aeruginosa PAO1 (MIC 2 uM), and K. pneumonia ATCC 700603 (MIC 2 uM).
Evidence 7 Activity

Activity

MIC
Antibacterial
2 µM

Target

Pseudomonas aeruginosa PAO1

Source & Reference

NA

Other

r CI 214 (MIC 0.25 uM), E. cloacae CI 4172 (MIC 2 uM), A. baumanii CI 2675 (MIC 0.25 uM), P. aeruginosa PAO1 (MIC 2 uM), and K. pneumonia ATCC 700603 (MIC 2 uM).
Evidence 8 Activity

Activity

MIC
Antibacterial
2 µM

Target

K. pneumonia ATCC 700603

Source & Reference

NA

Other

CI 4172 (MIC 2 uM), A. baumanii CI 2675 (MIC 0.25 uM), P. aeruginosa PAO1 (MIC 2 uM), and K. pneumonia ATCC 700603 (MIC 2 uM).
Evidence 9 Activity

Activity

<5% Hemolysis
Toxicity
128 µM
Hemolytic Cytotoxic
<5% Hemolysis | 128 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Mechanism of Action and Therapeutic Potential of the β-Hairpin Antimicrobial Peptide Capitellacin from the Marine Polychaeta Capitella teleta | Mar Drugs | 2022